CellVoyant ^Private

CellVoyant is an AI-first biotechnology company with a mission to cure chronic diseases through the development of stem cell therapies. They use AI-first live cell imaging to predict and optimize stem cell differentiation, allowing for the controllable manufacturing of any cell and tissue in the body at scale. CellVoyant operates at the intersection of cell biology, computer vision, engineering, and machine learning to bring next-generation science from research to the real world. With support from top venture capital firms and industry leaders in AI and biotech, CellVoyant is poised to revolutionize the field of regenerative medicine.